financial results
Sophia Genetics Q2 Revenue Grows 72 Percent
In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO.
SomaLogic Revenues Almost Triple in First Half of 2021
For the six months ended June 30, the Boulder, Colorado-based company posted revenues of $38.6 million, up from $13.4 million in the year-ago period.
Although demand for the firm's COVID-19 testing declined in H1, other diagnostic areas and its international business have grown.
Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover
The German rare disease diagnostics company had €51.9 million in Q2 revenues, significantly beating the average Wall Street estimate.
Biocartis H1 Revenues up 31 Percent
The revenue growth was driven by sales of the company's Idylla molecular diagnostics system and related test cartridges.
Aug 31, 2021
Burning Rock Q2 Revenues up 19 Percent
Aug 18, 2021
Ginkgo Bioworks H1 2021 Revenues Nearly Triple
Aug 18, 2021
Seegene Q2 Revenues up 11 Percent
Aug 17, 2021
Agilent Technologies Q3 Revenues Rise 26 Percent
Aug 16, 2021
Sema4 Reports 56 Percent Increase in Q2 Revenues
Aug 16, 2021
Biocept Q2 Revenues Continue COVID-19-Driven Spike
Aug 13, 2021
23andMe Q1 Revenues Rise 23 Percent
Aug 13, 2021
ProPhase Labs Posts 153 Percent Revenue Jump in Q2
Aug 12, 2021